Osprey Iliac: Occlusive/Stenotic Peripheral Artery Revascularization Study for Common And/Or External Iliac Artery Using the Misago RX Self-Expanding Peripheral Stent
ClinicalTrials.gov NCT02793492
Research payments
$796,792
Through program year 2025, $796,792 in research payments was reported against Osprey Iliac: Occlusive/Stenotic Peripheral Artery Revascularization Study for Common And/Or External Iliac Artery Using the Misago RX Self-Expanding Peripheral Stent, across 172 payments, paid by Terumo Medical Corporation.
- Paid by
- Terumo Medical Corporation
- ClinicalTrials.gov
- NCT02793492
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $117,035 | 48 |
| 2024 | Research | $375,967 | 74 |
| 2023 | Research | $287,289 | 48 |
| 2022 | Research | $16,500 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ehrin Armstrong Sacramento, CA Named on 30 payments
- Sameh Sayfo Plano, TX Named on 29 payments
- Mohammad Ansari Lubbock, TX Named on 15 payments
- Yazan Khatib Jacksonville, FL Named on 13 payments
- Ankur Lodha Lafayette, LA Named on 12 payments
- Gabriel Delgado Charlotte, NC Named on 11 payments
- John Rundback Teaneck, NJ Named on 11 payments
- John Corl Cincinnati, OH Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.